| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C18H27N |
| Molar mass | 257.421 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
2-Butyl-3-(p-tolyl)quinuclidine (BTQ) is astimulantDRI.[1] It is one of a number of substitutedquinuclidine derivatives developed as potential medications for the treatment ofcocaine abuse,[2] and produces similar effects to cocaine in animal studies, although milder and longer-lasting.
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |